Ozempic cost in 2026, with and without insurance
Paying cash, one Ozempic pen costs $349 for the 0.25, 0.5 and 1 mg doses and $499 for 2 mg; the list price is $1,028.
Ozempic is sold by Novo Nordisk as a pen that lasts about a month, and its price depends on who pays. A cash buyer using NovoCare Pharmacy or the TrumpRx coupon pays $349 for the 0.25, 0.5 or 1 mg pen and $499 for the 2 mg pen; someone starting treatment pays $199 for the first two fills until December 31, 2026. The list price, $1,028, is what an uninsured buyer is quoted without a program, and pharmacies pay about $996 for the pen according to CMS’s NADAC survey. Because Ozempic treats type 2 diabetes, Medicare Part D covers it: in 2026 your share stops at the $2,100 yearly cap, reached in July at list price. From January 2027 Medicare pays the negotiated price of $274 for 30 days, which brings the yearly share down to about $1,347.
The whole of 2026, by way of paying
- Paying cash (self-pay)$4,188
- Medicare Part D, covered use$2,100
- Medicaid, at a $4.00 copay$48
You would pay, Ozempic 1 mg
$349 / month
$4,188 in 2026
Self-pay price published by NovoCare Pharmacy / TrumpRx, the same through both.
Same dose, other ways to pay (per month)
- List price (wholesale acquisition cost)$1,028
- Self-pay: NovoCare Pharmacy or TrumpRx$349
- What pharmacies pay (NADAC)$996
- Medicare Part D, your share (month avg., 2026)$175
TrumpRx and makers read on October 16, 2026 · NADAC file of October 14, 2026. Estimate only, not medical advice. How it is calculated
Prices read by Radif Partners · Editorial policy · Method and data
A pen a month, and why 2 mg costs more
Each Ozempic pen holds several weekly doses. Novo Nordisk defines one month of self-pay treatment as one pen, so the bill does not follow the number of injections. Three of the four pens share one price, $349; the 2 mg pen, which holds 8 mg of semaglutide, costs $499. That jump is specific to Ozempic: Wegovy charges the same amount up to 2.4 mg.
| Pen | Self-pay a month | List price | Pharmacy cost (NADAC) | Medicare 2027 |
|---|---|---|---|---|
| 0.25 mg | $349 | $1,028 | $996 | $274 |
| 0.5 mg | $349 | $1,028 | $996 | $274 |
| 1 mg | $349 | $1,028 | $996 | $274 |
| 2 mg | $499 | $1,028 | $996 | $274 |
Medicare: covered, capped, then negotiated
Ozempic’s label covers type 2 diabetes, cardiovascular risk in people with diabetes and heart disease, and kidney protection in diabetes with chronic kidney disease, so Part D plans list it. Under the 2026 standard benefit you pay the first $615, then a quarter of the price until your share reaches $2,100. At list price that ceiling arrives in July, and every fill after that costs nothing. In 2027 two things change at once: the cap rises to $2,400 and the price used by Part D falls to $274, the figure CMS negotiated for all semaglutide products. The net effect is a lower bill, about $1,347 for the year. Ozempic prescribed only to lose weight is not a Part D drug, and it is not in the Medicare GLP-1 Bridge, which takes Wegovy instead.
Insured outside Medicare
If your employer plan covers Ozempic, the Novo Nordisk savings card can lower the copay to as little as $25, saving up to $100 a month. Plans often require a diabetes diagnosis; when coverage is denied, the self-pay price is the fallback, and it does not count toward the deductible.
The tablet alternative
Ozempic now also comes as a daily tablet, at $149 to $299 a month in cash. The label warns that tablets and injections are not interchangeable milligram for milligram, so a switch goes through your prescriber. Prices are on the Ozempic pill page.